Scoping insight on antiviral drugs against COVID-19
Background: COVID-19 is an ongoing viral pandemic produced by SARS-CoV-2. In light of in vitro efficacy, several medications were repurposed for its management. During clinical use, many of these medications produced inconsistent results or had varying limitations. Objective: The purpose of this lit...
Main Authors: | Ahmed S. Ali, Ibrahim M. Ibrahim, Abdulhadi S. Burzangi, Ragia H. Ghoneim, Hanin S. Aljohani, Hamoud A. Alsamhan, Jehan Barakat |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Arabian Journal of Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1878535221004007 |
Similar Items
-
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
by: Katya Uzunova, et al.
Published: (2020-11-01) -
SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
by: Cristina Adriana Dehelean, et al.
Published: (2020-07-01) -
Antiviral treatment of COVID-19: a clinical pharmacology narrative review
by: Instiaty, et al.
Published: (2020-07-01) -
COVID-19 possible medical treatments
by: Marzieh Mohammadi, et al.
Published: (2021-01-01) -
A narrative review of antiviral drugs used for COVID-19 pharmacotherapy
by: Subodh Kumar, et al.
Published: (2021-01-01)